Skip to main content
Springer logoLink to Springer
. 2018 Jan 4;16(1):145. doi: 10.1007/s40258-017-0364-4

Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer

Michel L Peters 1, Claudine de Meijer 2, Dirk Wyndaele 3, Walter Noordzij 4, Annemarie M Leliveld-Kors 5, Joan van den Bosch 6, Pieter H van den Berg 7, Agni Baka 1, Jennifer G Gaultney 8,
PMCID: PMC5797206  PMID: 29302922

Correction to: Appl Health Econ Health Policy 10.1007/s40258-017-0350-x

The article Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer, written by Michel L. Peters, Claudine de Meijer, Dirk Wyndaele, Walter Noordzij, Annemarie M. Leliveld-Kors, Joan van den Bosch, Pieter H. van den Berg, Agni Baka, Jennifer G. Gaultney was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 2nd September, 2017 without open access.

With the author(s)' decision to opt for Open Choice the copyright of the article changed on 24th November, 2017 to © The Author(s) 2017 and the article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, a link is provided to the Creative Commons license and any changes made are indicated. The original article was corrected.

Compliance with Ethical Standards

Funding

Open Access was funded by Bayer.

Footnotes

The original article can be found online at 10.1007/s40258-017-0350-x.


Articles from Applied Health Economics and Health Policy are provided here courtesy of Springer

RESOURCES